State Street Corp
- SEC CIK
- 0000093751
- Latest filing
- Sep 22, 2026
NRXP holding history
NRX Pharmaceuticals, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRXP overviewAll 13F holders of NRXPFull Q2 2026 holdings
- Shares (Q2 2026)
- 116,084
- Value
- $474.8K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 116,084 | $474.8K | <0.1% | +29,100+33.5% | Added | Holders |
| Q1 2026 | 86,984 | $185.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 86,984 | $235.7K | <0.1% | +10,700+14.0% | Added | Holders |
| Q3 2025 | 76,284 | $251.7K | <0.1% | +25,200+49.3% | Added | Holders |
| Q2 2025 | 51,084 | $166.5K | <0.1% | +7,360+16.8% | Added | Holders |
| Q1 2025 | 43,724 | $89.6K | <0.1% | +27,000+161.4% | Added | Holders |
| Q4 2024 | 16,724 | $36.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 16,724 | $28.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 16,724 | $40.8K | <0.1% | −97,516−85.4% | Reduced | Holders |
| Q1 2024 | 114,240 | $53.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 114,240 | $52.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 114,240 | $29.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 114,240 | $55.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 114,240 | $75.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 114,240 | $126.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 114,240 | $85.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 114,240 | $69.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 114,240 | $280.0K | <0.1% | +103,940+1,009.1% | Added | Holders |
| Q4 2021 | 10,300 | $49.0K | <0.1% | +10,300 | New | Holders |